Abstract
Objectives
We measured the accuracy of magnetic resonance elastography (MRE) for the detection and staging of liver fibrosis in chronic hepatitis B (CHB) and compared it with serum fibrosis markers.
Methods
Prospective comparison of MRE and routine serum fibrosis markers, namely serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST), ALT/AST ratio (AAR), AST to platelet ratio index (APRI) and prothrombin index (PI), was performed in 63 consecutive CHB patients who underwent MRE and histological confirmation of liver fibrosis within a 6-month interval. Diagnostic performance of MRE and serum markers for staging fibrosis (≥F1), significant fibrosis (≥F2), advanced fibrosis (≥F3) and cirrhosis (F4) was compared.
Results
The study group comprised 63 patients (19 female; mean age ± SD, 50 ± 11.9 years). MRE (ρ = 0.94, P < 0.0001), APRI (ρ = 0.42, P = 0.0006), PI (ρ = 0.42, P = 0.0006) and AST (ρ = 0.28, P = 0.028) results correlated significantly with fibrosis stage. MRE was significantly more accurate than serum fibrosis markers for the detection of significant fibrosis (0.99 vs. 0.55–0.73) and cirrhosis (0.98 vs. 0.53–0.77). Sensitivity, specificity, positive predictive and negative predictive values for MRE for significant fibrosis and cirrhosis were 97.4 %, 100 %, 100 % and 96 %, and 100 %, 95.2 %, 91.3 % and 100 %, respectively.
Conclusion
MRE is an accurate non-invasive technique for the detection and staging of liver fibrosis in CHB.
Key Points
• Magnetic resonance elastography is accurate for liver fibrosis detection and staging.
• MR elastography is more accurate than serum tests for staging liver fibrosis.
• MR elastography can potentially replace liver biopsy in chronic hepatitis B.
Similar content being viewed by others
References
Liver EAFTSOT (2012) EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57:167–185
Fattovich G (2003) Natural history and prognosis of hepatitis B. Semin Liver Dis 23:47–58
McMahon BJ (2004) The natural history of chronic hepatitis B virus infection. Semin Liver Dis 24:17–21
Hadziyannis SJ, Papatheodoridis GV (2006) Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis 26:130–141
Fattovich G, Olivari N, Pasino M, D'Onofrio M, Martone E, Donato F (2008) Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. Gut 57:84–90
Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:S35–S50
Bosch FX, Ribes J, Cléries R, Díaz M (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9:191–211
Lok AS, McMahon BJ (2009) Chronic hepatitis B: update 2009. Hepatology 50:661–662
Dienstag JL, Goldin RD, Heathcote EJ et al (2003) Histological outcome during long-term lamivudine therapy. Gastroenterology 124:105–117
Marcellin P, Chang TT, Lim SG et al (2008) Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. Hepatology 48:750–758
Chang TT, Liaw YF, Wu SS et al (2010) Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 52:886–893
Liver EAFTSOT (2009) EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 50:227–242
Castéra L, Nègre I, Samii K, Buffet C (1999) Pain experienced during percutaneous liver biopsy. Hepatology 30:1529–1530
Castera L (2011) Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol 25:291–303
Piccinino F, Sagnelli E, Pasquale G, Giusti G (1986) Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2:165–173
Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495–500
Cadranel JF, Rufat P, Degos F (2000) Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 32:477–481
Regev A, Berho M, Jeffers L et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614–2618
Maharaj B, Maharaj R, Leary W et al (1986) Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1:523–525
Wai CT, Greenson JK, Fontana RJ et al (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518–526
Castera L (2012) Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 142:1293–1302, e1294
Rockey DC, Bissell DM (2006) Noninvasive measures of liver fibrosis. Hepatology 43:S113–S120
Halfon P, Bacq Y, De Muret A et al (2007) Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 46:395–402
Chan HL, Wong GL, Choi PC et al (2009) Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 16:36–44
Wong GL, Wong VW, Choi PC et al (2008) Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol 6:1027–1035
Castéra L, Foucher J, Bernard PH et al (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828–835
Friedrich-Rust M, Nierhoff J, Lupsor M et al (2012) Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 19:e212–e219
Sporea I, Sirli R, Popescu A, Danilă M (2010) Acoustic radiation force impulse (ARFI)–a new modality for the evaluation of liver fibrosis. Med Ultrason 12:26–31
Yin M, Talwalkar JA, Glaser KJ et al (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:1207–1213, e1202
Huwart L, Sempoux C, Salameh N et al (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245:458–466
Huwart L, Sempoux C, Vicaut E et al (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135:32–40
Rustogi R, Horowitz J, Harmath C et al (2012) Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 35:1356–1364
Wang Y, Ganger DR, Levitsky J et al (2011) Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 196:553–561
Godfrey EM, Patterson AJ, Priest AN et al (2012) A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol 22:2790–2797
Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56:239–247
Kim BH, Lee JM, Lee YJ et al (2011) MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. J Magn Reson Imaging 34:1110–1116
Ichikawa S, Motosugi U, Ichikawa T et al (2012) Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci 11:291–297
Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL (2011) Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259:749–756
Vizzotto L, Vertemati M, Gambacorta M, Sabatella G, Goffredi M, Minola E (2005) Computerized morphometry in liver cirrhosis: histological and immunohistochemical properties. In: Liver cirrhosis: new research. Nova Science, New York, p 97–112
Yano M, Kumada H, Kage M et al (1996) The long-term pathological evolution of chronic hepatitis C. Hepatology 23:1334–1340
Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O, Yano M (1997) Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology 25:1028–1031
Marcellin P, Ziol M, Bedossa P et al (2009) Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 29:242–247
Vizzotto L, Vertemati M, Gambacorta M, Sabatella G, Spina V, Minola E (2002) Analysis of histological and immunohistochemical patterns of the liver in posthepatitic and alcoholic cirrhosis by computerized morphometry. Mod Pathol 15:798–806
Bensamoun SF, Leclerc GE, Debernard L et al (2013) Cutoff values for alcoholic liver fibrosis using magnetic resonance elastography technique. Alcohol Clin Exp Res 37:811–817
Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL (2013) Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology. doi:10.1148/radiol.13121193
Bohte AE, van Dussen L, Akkerman EM et al (2013) Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage. PLoS One 8:e57507
Venkatesh SK, Yin M, Ehman RL (2013) Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Res Imaging 37:544–555
Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289–293
Motosugi U, Ichikawa T, Sano K et al (2010) Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability. Jpn J Radiol 28:623–627
Hines CDG, Bley TA, Lindstrom MJ, Reeder SB (2010) Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Res Imaging 31:725–731
Shire NJ, Yin M, Chen J et al (2011) Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C. J Magn Reson Imaging 34:947–955
Fraquelli M, Rigamonti C, Casazza G et al (2011) Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol 54:621–628
Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, Elkashab M (2010) Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int 30:1471–1480
Poynard T, Halfon P, Castera L et al (2007) Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 53:1615–1622
Asbach P, Klatt D, Hamhaber U et al (2008) Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med 60:373–379
Mariappan YK, Venkatesh SK, Glaser KJ, McGee KP, Ehman RL (2013) MR elastography of liver with iron overload: development, evaluation and preliminary clinical experience with improved spin echo and spin echo EPI sequences. Proceedings of the 21st annual meeting of ISMRM, Salt Lake City, 2012 (abstract 985)
Acknowledgement
We acknowledge the support provided by the Individual Research Grant (IRG 1163/2008) from the National Medical Research Council, Singapore.We would like to thank Dr. Richard L. Ehman and the Buzz group, Mayo Clinic, Rochester, MN, USA for their support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Venkatesh, S.K., Wang, G., Lim, S.G. et al. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol 24, 70–78 (2014). https://doi.org/10.1007/s00330-013-2978-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-013-2978-8